Your browser doesn't support javascript.
loading
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.
Mazzaferri, Fulvia; Mirandola, Massimo; Savoldi, Alessia; De Nardo, Pasquale; Morra, Matteo; Tebon, Maela; Armellini, Maddalena; De Luca, Giulia; Calandrino, Lucrezia; Sasset, Lolita; D'Elia, Denise; Sozio, Emanuela; Danese, Elisa; Gibellini, Davide; Monne, Isabella; Scroccaro, Giovanna; Magrini, Nicola; Cattelan, Annamaria; Tascini, Carlo; Tacconelli, Evelina.
Affiliation
  • Mazzaferri F; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Mirandola M; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Savoldi A; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • De Nardo P; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Morra M; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Tebon M; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Armellini M; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • De Luca G; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Calandrino L; Infectious Disease Unit, Padova University Hospital, Padua, Italy.
  • Sasset L; Infectious Disease Unit, Padova University Hospital, Padua, Italy.
  • D'Elia D; Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Sozio E; Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Danese E; Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
  • Gibellini D; Microbiology and Virology Unit, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Monne I; Viral genomics and transcriptomics Laboratory, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.
  • Scroccaro G; Direzione Farmaceutico, Protesica, Dispositivi Medici, Regione del Veneto, Venice, Italy.
  • Magrini N; Italian Medicines Agency, Rome, Italy.
  • Cattelan A; Infectious Disease Unit, Padova University Hospital, Padua, Italy.
  • Tascini C; Infectious Diseases Division, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Tacconelli E; Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Elife ; 112022 11 22.
Article in En | MEDLINE | ID: mdl-36413383
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Elife Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Elife Year: 2022 Document type: Article Affiliation country: Country of publication: